Showing results (1-10 of 818) with videos related to

Sort By:
Pageof 82
Current Opinion in Lipidology|July 11, 2007
Antisense apolipoprotein B therapy: where do we stand?Fatima Akdim, Erik S G Stroes, John J P Kastelein
Current Pharmaceutical Design|April 14, 2007
Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?Fatima Akdim, Sander I van Leuven, John J P Kastelein, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 12, 2008
Current and future pharmacologic options for the management of patients unable to achieve low-density lipoprotein-cholesterol goals with statinsKarim El Harchaoui, Fatima Akdim, Erik S G Stroes, et al.
Journal of Lipid Research|December 17, 2009
Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemiaMaartje E Visser, Fatima Akdim, Diane L Tribble, et al.
European Heart Journal|May 20, 2011
Efficacy of apolipoprotein B synthesis inhibition in subjects with mild-to-moderate hyperlipidaemiaFatima Akdim, Diane L Tribble, JoAnn D Flaim, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 20, 2020
[Gene Therapy Office; the Potemkin village of the Ministry of Infrastructure and Water Management]John J P Kastelein
Nature Reviews. Cardiology|September 10, 2014
Decade in review--dyslipidaemia: Resurgence of targets and compounds to treat dyslipidaemiaJohn J P Kastelein
The American Journal of Cardiology|December 6, 2007
Refocusing on use of cholesteryl ester transfer protein inhibitorsJohn J P Kastelein
Pageof 82